Skip to content
AbbVie

AbbVie

ABBV-951 (LDP/LCD infusion)is a dopamine precursor delivered via continuous infusion, targeting motor impairment. This treatment provides levodopa/carbidopa in a more controlled and continuous manner to manage motor symptoms more effectively.

Cart 0

Your cart is currently empty.

Start Shopping